Pathogenesis
- Inhibition or Deficiency of the von Willebrand factor cleaving protease ADAMTS13
- Acquired TTP (95%): autoantibodies against ADAMTS13
- Drug associations: cyclosporine, tacrolimus, sirolimus, ticlopidine, clopidogrel, statins, valacyclovir (in HIV)
- Congenital TTP (5%): gene mutation
- HUS linked to E. coli infection O157:H7 (toxin-mediated endothelial injury)
- Less degradation of vWF multimers → large vWF multimers → platelet adhesion and microthrombosis
- → fragmentation of RBCs → hemolytic anemia
Apresentação Clínica
- Pentad (only 20% have all 5 present)
- Thrombocytopenia
- Hemolytic anemia
- Renal abnormalities
- Fever
- CNS disturbances
- Splenomegaly
- Shistocyte
Biopsy: hemorrhage and fibrin occlusion of vessels with absent inflammation
- Treatment: 80% survival with exchange plasmapheresis
- Other treatments include corticosteroids and splenectomy
DDx
- DIC → look for alterations in PT and APTT